465
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Effects of two different lipid emulsions on morbidities and oxidant stress statuses in preterm infants: an observational study

, , , , , & show all
Pages 850-856 | Received 04 Aug 2016, Accepted 06 Feb 2017, Published online: 15 Mar 2017
 

Abstract

Objective: We examined the morbidities and oxidative stress statuses in preterms receiving either SMOFlipid or ClinOleic.

Study design: This observational study was performed in Etlik Zubeyde Hanim Hospital, Turkey. Infants received SMOFlipid (5 months) or ClinOleic (7 months). Two hundred and twenty seven infants (SMOFlipid: 93, ClinOleic: 134) very low birth weighted infants were included. The oxidative stress status was evaluated in infants at low risk of oxidative stress by total antioxidant capacity (TAC) and total oxidant status (TOS) and oxidative stress index (OSI; TAC/TOS/100) at baseline, first week and third week.

Results: Parenteral nutrition was given for a median of 7 days in both groups. There were statistically insignificantly higher rates of retinopathy of prematurity (9.4 versus 11.7%) and chronic lung disease (4.7 versus 6.7%) in ClinOleic group compared with SMOFlipid group. The TAC, TOS and OSI decreased significantly in ClinOleic group after 1 week, and although the results were not statistically significant, the TAC increased while the TOS and OSI decreased in SMOFlipid group. In both groups, the TAC, TOS and OSI were lower than baseline after 3 weeks.

Conclusion: SMOFlipid and ClinOleic result in similar oxidative stress statuses after they were stopped, and we detected no statistically significant differences in morbidity rates.

Acknowledgements

We would like to thank to Özcan Erel, MD, Professor of Biochemistry (Yıldırım Beyazıt University Medical Faculty, Department of Biochemistry, Ankara, Turkey) and Murat Alışık, MD, Research Assistant (Ankara Atatürk Training and Research Hospital, Department of Biochemistry, Ankara, Turkey) for measuring serum TAC and TOS levels.

Disclosure statement

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.